US 11731968
Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
granted A61KA61K31/4745A61P
Quick answer
US patent 11731968 (Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death) held by HEPAREGENIX GMBH expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HEPAREGENIX GMBH
- Grant date
- Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/4745, A61P, A61P31/20